Collaboration includes two therapeutic candidates – MP0420 and MP0423
French pharma will test investigational candidate alongside MSD’s Keytruda
New guidance based on research from University of Manchester
Agreement will also see companies develop treatments for frontotemporal dementia
Accentuate the … non-obvious? Trend-watcher coaches pharma marketers on offbeat thinking bbulik Wed, 10/28/2020 – 17:18
Significant gaps exist in the quality and availability of official published data on the covid-19 pandemic in England, […]
The government has not done enough to protect the UK’s black, Asian, and minority ethnic (BAME) communities ahead […]
Public health experts and international organisations increasingly recommend wearing masks to help limit the spread of covid-19.1 Safe […]
Covid-19-related deaths increased by more than 50% in the week ending 16 October, compared with the week before, […]
Indian drugmaker failed to notify FDA multiple times about issues with its sterile injectables: letter kblankenship Wed, 10/28/2020 […]